Two P2Y12 inhibitors often used interchangeably, ticagrelor and prasugrel (antiplatelet medications prescribed to prevent the formation of blood clots), had different impacts on outcomes in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results